{"id":425334,"date":"2026-01-22T07:22:10","date_gmt":"2026-01-22T07:22:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/425334\/"},"modified":"2026-01-22T07:22:10","modified_gmt":"2026-01-22T07:22:10","slug":"ontario-pharmacy-regulator-dismisses-complaint-about-restrictions-on-teachers-drug-plan","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/425334\/","title":{"rendered":"Ontario pharmacy regulator dismisses complaint about restrictions on teachers\u2019 drug plan"},"content":{"rendered":"<p><a style=\"display:block\" href=\"https:\/\/www.theglobeandmail.com\/resizer\/v2\/UITCZPECUVDW5MHLZEIR5BPXGE.jpg?auth=76e7c039b69273008501cc6f410462831e0dde420771c9ac2fca6ce8f0ef1300&amp;width=600&amp;height=400&amp;quality=80&amp;smart=true\" aria-haspopup=\"true\" data-photo-viewer-index=\"0\" rel=\"nofollow noopener\" target=\"_blank\">Open this photo in gallery:<\/a><\/p>\n<p class=\"figcap-text\">Ontario teacher Amy Miller was told she would lose coverage for a drug she relies on to manage a painful condition unless she filled her prescription with a pharmacy owned by the Ontario Teachers Insurance Plan.Sarah Palmer\/The Globe and Mail<\/p>\n<p class=\"c-article-body__text text-pr-5\">A disciplinary panel of Ontario\u2019s pharmacy regulator has dismissed a <a href=\"https:\/\/www.theglobeandmail.com\/business\/article-ontario-regulator-to-hear-concerns-over-teachers-insurance-restricting\/\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.theglobeandmail.com\/business\/article-ontario-regulator-to-hear-concerns-over-teachers-insurance-restricting\/\">complaint about a specialty-drug pharmacy<\/a> created for the Ontario Teachers Insurance Plan that takes away teachers\u2019 choice of where they fill prescriptions if they want to keep their drug coverage. But the decision in favour of OTIP\u2019s pharmacy, MemberRx, goes directly against the regulator\u2019s own zero-tolerance position against such deals, advocates say.<\/p>\n<p class=\"c-article-body__text text-pr-5\">A teacher, Amy Miller, <a href=\"https:\/\/www.theglobeandmail.com\/business\/article-ontario-teacher-faces-running-out-of-specialty-drug-while-complaint\/\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.theglobeandmail.com\/business\/article-ontario-teacher-faces-running-out-of-specialty-drug-while-complaint\/\">first submitted her complaint<\/a> to the Ontario College of Pharmacists in August of 2024 against three pharmacists who are directors of MemberRx. Ms. Miller was told she would lose coverage for a drug she relies on to manage a painful condition unless she filled her prescription with MemberRx. <\/p>\n<p class=\"c-article-body__text text-pr-5\">The complaint alleged professional misconduct because the pharmacists had, among other actions, struck \u201can agreement that restricts a person\u2019s choice of pharmacist without their consent.\u201d <\/p>\n<p class=\"c-article-body__text text-pr-5\">The decision reveals gaps in the regulation of controversial deals known as \u201cpreferred pharmacy networks,\u201d or PPNs. These agreements between insurers and pharmacies dictate where plan members can receive their drugs. The college itself issued a zero-tolerance statement on PPNs in the summer of 2024, stating that such models present a \u201cpotential risk of harm to patients.\u201d <\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/business\/economy\/article-inside-the-2-million-loophole-that-lets-corporations-own-pharmacies-in\/\" rel=\"nofollow noopener\" target=\"_blank\">Inside the $2-million loophole that lets corporations own pharmacies in Ontario<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cI don\u2019t know why they would have a zero-tolerance policy, and then not be able to enforce it,\u201d said Justin Bates, chief executive officer of the Ontario Pharmacists Association (OPA). He added that the decision in Ms. Miller\u2019s case was \u201cinconsistent\u201d with that policy and \u201cdisappointing.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">Late last year, Ontario announced it would pass a new law <a href=\"https:\/\/www.theglobeandmail.com\/business\/economy\/article-ontario-ban-drug-insurance-pharmacy-exclusivity-deals-ppns-closed\/\" rel=\"nofollow noopener\" target=\"_blank\">banning such exclusive deals<\/a>. But regulations are still under development, and they would apply to insurers rather than pharmacists. The directors of MemberRx all argued during the complaint-review process that the appropriate venue for Ms. Miller\u2019s complaint was the Ontario government\u2019s consultation on that law, and not the college. <\/p>\n<p class=\"c-article-body__text text-pr-5\">The decision of the college\u2019s disciplinary panel, issued on Jan. 14 and obtained by The Globe and Mail, concluded it would take no action against the MemberRx directors. The panel noted that it has no jurisdiction over PPNs, and that many of the issues raised by the complaint \u201care matters of policy rather than professional regulation.\u201d It also wrote in the decision that \u201cthere is currently no legislation or other mechanism\u201d prohibiting pharmacists from practising at a PPN pharmacy.<\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cI think that\u2019s a cop-out,\u201d the OPA\u2019s Mr. Bates said.<\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cWhile we cannot comment on the specifics of this confidential investigation, we recognize that the complainant\u2019s experience reflects broader concerns about the impacts of closed Preferred Provider Networks (PPNs) on patient care,\u201d college spokesperson Nancy Schlomer wrote in a statement to The Globe, adding that the college continues to contribute to the government process to develop regulations.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Ms. Miller takes a specialty drug to manage her ankylosing spondylitis arthritis, a condition characterized by painful inflammation of the spine. The drug, Humira, costs more than $30,000 a year \u2013 an expense she cannot afford without her insurance coverage. <\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/canada\/article-health-canada-foreign-regulators-drug-approvals\/\" rel=\"nofollow noopener\" target=\"_blank\">Health Canada considering using decisions of foreign regulators for some drug approvals<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">In 2023, OTIP informed its plan members that they would have to use MemberRx exclusively in future in order to maintain coverage for some drugs. Then, in the spring of 2024, OTIP informed Ms. Miller she must switch to the pharmacy.<\/p>\n<p class=\"c-article-body__text text-pr-5\">She filed the complaint with the college after requests to remain with a local pharmacist she trusts to manage her condition were denied. The OPA was able to help Ms. Miller secure third-party compassionate care coverage while she filed her complaint. Now, she only has about 40 days of medication left, but the OPA says it will work to help her secure continued access to it.<\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cPharmacists are a key point of contact in our health care,\u201d Ms. Miller said, adding that MemberRx would not keep track of the full scope of her medications the way her local pharmacist does. \u201cThat, to me, is invaluable.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">MemberRx is a new type of model called a \u201cplan sponsor pharmacy,\u201d which is owned by the insurance plan itself. Similar to a PPN, it directs members exclusively to a designated pharmacy.<\/p>\n<p class=\"c-article-body__text text-pr-5\">MemberRx was designed and set up for OTIP by a Toronto-based consultancy called Cubic Health Inc., which charges OTIP a fee for its services, including hiring pharmacy staff and establishing wholesale relationships. All three of the directors of MemberRx who were named in the complaint \u2013 Xiaofei Huang, Bishoy Khalil and Michael Sullivan \u2013 also hold paid leadership positions at Cubic. But they denied that this was a conflict of interest, because any profits from MemberRx are directed back into the plan. <\/p>\n<p class=\"c-article-body__text text-pr-5\">Complaints to the college are reviewed by a panel of pharmacy professionals and members of the public. The panel in this case found there was \u201cinsufficient information\u201d demonstrating a conflict of interest.<\/p>\n<p class=\"c-article-body__text text-pr-5\">Through their lawyers in response to the complaint, the pharmacists noted that the Employee Life and Health Trusts of the Ontario teachers\u2019 unions \u201chave a fiduciary obligation to balance providing comprehensive coverage in a sustainable manner and have concluded that a PPN model is necessary to achieve these objectives by reducing the cost of the coverage provided.\u201d <\/p>\n<p class=\"c-article-body__text mv-16 l-inset text-pb-8\" data-sophi-feature=\"interstitial\"><a href=\"https:\/\/www.theglobeandmail.com\/business\/economy\/article-pet-pharmacies-veterinary-prescriptions-medications\/\" rel=\"nofollow noopener\" target=\"_blank\">New pet pharmacies could help owners manage rising costs as access opens up<\/a><\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cWe have confidence in the professionalism and care demonstrated by MemberRx throughout this process,\u201d Mr. Sullivan, Cubic Health\u2019s CEO and a MemberRx director, wrote in a statement to The Globe. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cIn its review, the Panel found no evidence that MemberRx limited a patient\u2019s choice of pharmacist, disrupted continuity of care, or placed business interests ahead of the patient\u2019s wellbeing,\u201d he wrote. <\/p>\n<p class=\"c-article-body__text text-pr-5\">The decision also noted that Ms. Miller initially signed a consent form to transfer her prescription to MemberRx after she first received the communication from OTIP in 2023. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cTelling someone they would have to pay $33,000 for a quality-of-life-altering medication, that\u2019s not free consent,\u201d said Ms. Miller\u2019s lawyer, Aly Haji. <a href=\"https:\/\/www.theglobeandmail.com\/canada\/ontario\/\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" title=\"https:\/\/www.theglobeandmail.com\/canada\/ontario\/\">Ontario<\/a> law specifies that consent must be voluntary and free from duress, he added. \u201cThat is duress.\u201d <\/p>\n<p class=\"c-article-body__text text-pr-5\">Mr. Haji noted that the regulator\u2019s zero-tolerance position on PPNs should apply to models that restrict patient autonomy. <\/p>\n<p class=\"c-article-body__text text-pr-5\">\u201cWhat they did is completely incongruent with that.\u201d<\/p>\n<p class=\"c-article-body__text text-pr-5\">Ms. Miller plans to appeal.<\/p>\n","protected":false},"excerpt":{"rendered":"Open this photo in gallery: Ontario teacher Amy Miller was told she would lose coverage for a drug&hellip;\n","protected":false},"author":2,"featured_media":425335,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[901,888,902,879,877,903,49,48,876,895,896,891,878,875,46,549,295,894,887,914,880,881,893,84,392,889,890,884,904,885,909,910,912,907,911,905,908,882,898,899,714,897,906,865,61,900,892,886,883,913],"class_list":["post-425334","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-alberta","tag-arts-news","tag-bc","tag-breaking-news","tag-breaking-news-video","tag-british-columbia","tag-ca","tag-canada","tag-canada-news","tag-canada-sports","tag-canada-sports-news","tag-canada-trafficcanada-weather","tag-canadian-breaking-news","tag-canadian-news","tag-economy","tag-education","tag-environment","tag-federal-government","tag-foreign-news","tag-globe-and-mail","tag-globe-and-mail-breaking-news","tag-globe-and-mail-canada-news","tag-government","tag-health","tag-healthcare","tag-life-news","tag-lifestyle","tag-local-news","tag-manitoba","tag-national-news","tag-new-brunswick","tag-newfoundland-and-labrador","tag-northwest-territories","tag-nova-scotia","tag-nunavut","tag-ontario","tag-pei","tag-photos","tag-political-news","tag-political-opinion","tag-politics","tag-politics-news","tag-quebec","tag-sports-news","tag-technology","tag-travel","tag-trudeau","tag-us-news","tag-world-news","tag-yukon"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/425334","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=425334"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/425334\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/425335"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=425334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=425334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=425334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}